Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
D000328:Adult; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism*; D001646:Bile / Q000032:analysis; D001658:Biliary Fistula / Q000378:metabolism; D001798:Blood Proteins / Q000032:analysis; D002247:Carbon Isotopes; D002606:Charcoal / Q000494:pharmacology; D004064:Digestive System / Q000378:metabolism; D004285:Dogs; D005243:Feces / Q000032:analysis; D005260:Female; D005333:Fetus / Q000032:analysis; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000652:urine; D005461:Fluorine / Q000378:metabolism; D005470:Fluorometry; D000882:Haplorhini; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008431:Maternal-Fetal Exchange; D008528:Mefenamic Acid / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000652:urine; D008722:Methods; D011247:Pregnancy; D011485:Protein Binding; D062367:ortho-Aminobenzoates / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D002247:Carbon Isotopes; D062367:ortho-Aminobenzoates; D002606:Charcoal; D005461:Fluorine; D008528:Mefenamic Acid; D005439:Flufenamic Acid